Cable Hill Partners, LLC Amicus Therapeutics, Inc. Transaction History

Cable Hill Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$10.96 - $14.4 $1,841 - $2,419	-168 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$11.6 - $16.54 $6,148 - $8,766	-530 Reduced 75.93%	168 $2,000
Q2 2018 Aug 03, 2018	SELL	$13.13 - $17.09 $3,282 - $4,272	-250 Reduced 26.37%	698 $11,000
Q1 2018 Apr 20, 2018	BUY	$13.76 - $17.12 $5,792 - $7,207	421 Added 79.89%	948 $12,000
Q3 2017 Oct 27, 2017	SELL	$11.74 - $15.78 $5,553 - $7,463	-473 Reduced 47.3%	527 $8,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,000	1,000 $10,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.